Browsing by Author Wark, Peter

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2010Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonistReddel, Helen; Gibson, Peter; Hoyos, Camilla; Jenkins, Christine; Peters, Matthew J; Sand, Ingrid; Wark, Peter; Central Clinical School: Woolcock Inst. of Medical ResearchDown-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist, Respiratory Medicine, vol.104, 8,pp 1110-1120
2014The Effect of Inhaled IFN-b on Worsening of Asthma Symptoms Caused by Viral InfectionsReddel, Helen; Davies, Donna; Djukanovic, Ratko; et al, Various; Gabbay, Flic; Harrison, Tim W.; Johnston, Sebastian L.; Niven, Robert; Singh, Dave; Thomson, Neil; Wark, Peter; Central Clinical School: Woolcock Inst. of Medical ResearchThe Effect of Inhaled IFN-b on Worsening of Asthma Symptoms Caused by Viral Infections, American Journal of Respiratory and Critical Care Medicine, vol.190, 2, 2014,pp 145-154
2013Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN)Dwyer, Dominic; Brown, Simon; Cheng, Allen C; et al, Various; Friedman, N Deborah; Hewagama, Saliya; Holmes, Mark; Senenayake, Sanjaya; Simpson, Graham; Upham, John; Wark, Peter; Waterer, Grant W.; Western Clinical School: Medicine (Westmead)Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN), Communicable Diseases Intelligence, vol.37, 3, 2013,pp E246-E252
2015Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014Dwyer, Dominic; Macartney, Kristine; Cheng, Allen C; et al, Various; Friedman, Deborah; Hewagama, Saliya; Hunter, Cameron; Kelly, Paul M.; Korman, Tony M.; Kotsimbos, Tom; Simpson, Graham; Wark, Peter; Western Clinical School: Medicine (Westmead); Childrens Hospital Westmead: Paediatrics & Child HealthInfluenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014, Vaccine, vol.33, 51, 2015,pp 7352-7356
2012RAGE: a new frontier in chronic airways diseaseArmour, Carol; Hughes, J. Margaret; Sukkar, Maria; Ullah, Md; Chung, K. Fan; Gan, Wan; Phipps, Simon; Wark, Peter; Northern Clinical School: Pharmacology; Pharmacy; Pharmacy; Central Clinical School: Woolcock Inst. of Medical ResearchRAGE: a new frontier in chronic airways disease, British Journal of Pharmacology, vol.N/A, N/A, 2012,pp N/A-N/A
2016A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosisBye, Peter; Dentice, Ruth; Elkins, Mark; Harmer, Christopher John; Hu, Honghua; Middleton, Peter; Bishop, Jennifer R; Dorahy, Douglas J; Wark, Peter; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical ResA randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis, Thorax, vol.71, 2, 2016,pp 141-147
2016Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaGuo, Michael; Marks, Guy; Reddel, Helen; Rimmer, Janet; Robinson, Paul; Bowden, Jeffrey; et al, Various; Gillman, Andrew J.; Hew, Mark; Jenkins, C R; Sutherland, Megan K.; Thien, Francis; Wark, Peter; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Childrens Hospital Westmead: Paediatrics & Child HealthReal-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria, Clinical and Experimental Allergy, vol.46, 11, 2016,pp 1407-1415
2016Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaGuo, Michael; Marks, Guy; Reddel, Helen; Rimmer, Janet; Robinson, Paul; Bowden, Jeffrey; et al, Various; Gillman, Andrew J.; Hew, Mark; Jenkins, C R; Sutherland, Megan K.; Thien, Francis; Wark, Peter; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Childrens Hospital Westmead: Paediatrics & Child HealthReal-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria, Clinical and Experimental Allergy, vol.46, 11, 2016,pp 1407-1415
2008Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophagesBlack, Judith; Burgess, Janette; King, Nicholas; Lim, Sam; Oliver, Brian; Roth, Michael; Johnston, Sebastian; Laza-Stanca, V; Wark, Peter; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pathology; Concord Clinical School: ANZAC Research Institute; School of Medical Sciences: Pharmacology; Central Clinical School: Woolcock Inst. of Medical ResearchRhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages, Thorax, vol.63,(6),2008,pp 519-525
2017Severe asthma: Current management, targeted therapies and future directions - A roundtable reportKing, Gregory; Marks, Guy; Reddel, Helen; Smith, Lorraine; Gibson, Peter G.; James, Alan L; Maltby, Steven; McDonald, Vanessa M.; Upham, John; Wark, Peter; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; Central Clinical School: Woolcock Inst. of Medical Research; PharmacySevere asthma: Current management, targeted therapies and future directions - A roundtable report, Respirology, vol.22, 1, 2017,pp 53-60